Solved

Passage Nuclear Medicine Uses Radiopharmaceuticals for Disease Treatment and as Tracers

Question 5

Multiple Choice

Passage
Nuclear medicine uses radiopharmaceuticals for disease treatment and as tracers in medical imaging studies.  Yttrium-90 (90Y) is a radiopharmaceutical agent used to treat overgrown joint lining known as pigmented villonodular synovitis, as well as some forms of liver cancer.  It has a half-life of about 64 hours.Although the relatively short half-life of 90Y is optimal for use in medical applications, transportation and storage of the radiopharmaceutical are not feasible.  As a result, strontium-90 (90Sr) , with a half-life of 28.8 years, is the most common source of 90Y.  90Sr is created by a nuclear fission process that begins with uranium-235 (235U) in a nuclear reactor as shown in Reaction 1.235U → 90Sr + ZReaction 1Fission of 235U produces 90Sr as well as additional fission products (Z) including, but not limited to, technetium-99 (99Tc) , iodine-129 (129I) , and zirconium-93 (93Zr) .  Figure 1 shows the distribution of fission products.
Passage Nuclear medicine uses radiopharmaceuticals for disease treatment and as tracers in medical imaging studies.  Yttrium-90 (<sup>90</sup>Y)  is a radiopharmaceutical agent used to treat overgrown joint lining known as pigmented villonodular synovitis, as well as some forms of liver cancer.  It has a half-life of about 64 hours.Although the relatively short half-life of <sup>90</sup>Y is optimal for use in medical applications, transportation and storage of the radiopharmaceutical are not feasible.  As a result, strontium-90 (<sup>90</sup>Sr) , with a half-life of 28.8 years, is the most common source of <sup>90</sup>Y.  <sup>90</sup>Sr is created by a nuclear fission process that begins with uranium-235 (<sup>235</sup>U)  in a nuclear reactor as shown in Reaction 1.<sup>235</sup>U → <sup>90</sup>Sr + Z<strong>Reaction 1</strong>Fission of <sup>235</sup>U produces <sup>90</sup>Sr as well as additional fission products (Z)  including, but not limited to, technetium-99 (<sup>99</sup>Tc) , iodine-129 (<sup>129</sup>I) , and zirconium-93 (<sup>93</sup>Zr) .  Figure 1 shows the distribution of fission products.    <strong>Figure 1</strong>  Distribution of <sup>235</sup>U fission products by atomic weightTo create the final <sup>90</sup>Y required for nuclear medicine studies, <sup>90</sup>Sr decay is carried out in a controlled <sup>90</sup>Y generator.  <sup>90</sup>Y is then separated from residual <sup>90</sup>Sr for use in clinical applications. Adapted from Wheeler CE. Comments on vaccines, August 1987. J Am Acad Dermatol. 1988;18(1 Pt 2) :232-4. -Fission of <sup>235</sup>U produces multiple elements.  Based on Figure 1, which of the following is the atomic number of the most common fission product? A) 38 B) 55 C) 92 D) 133 Figure 1  Distribution of 235U fission products by atomic weightTo create the final 90Y required for nuclear medicine studies, 90Sr decay is carried out in a controlled 90Y generator.  90Y is then separated from residual 90Sr for use in clinical applications.
Adapted from Wheeler CE. Comments on vaccines, August 1987. J Am Acad Dermatol. 1988;18(1 Pt 2) :232-4.
-Fission of 235U produces multiple elements.  Based on Figure 1, which of the following is the atomic number of the most common fission product?


A) 38
B) 55
C) 92
D) 133

Correct Answer:

verifed

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Related Questions

Unlock this Answer For Free Now!

View this answer and more for free by performing one of the following actions

qr-code

Scan the QR code to install the App and get 2 free unlocks

upload documents

Unlock quizzes for free by uploading documents